StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS – Free Report) in a research note released on Tuesday. The firm issued a hold rating on the stock.
Milestone Scientific Stock Up 3.6 %
Milestone Scientific stock opened at $0.73 on Tuesday. The business’s 50-day simple moving average is $0.67 and its 200 day simple moving average is $0.66. The stock has a market cap of $56.35 million, a price-to-earnings ratio of -7.30 and a beta of 0.90. Milestone Scientific has a 12-month low of $0.52 and a 12-month high of $1.35.
Milestone Scientific (NYSE:MLSS – Get Free Report) last released its earnings results on Wednesday, May 15th. The company reported ($0.02) earnings per share for the quarter. Milestone Scientific had a negative net margin of 74.50% and a negative return on equity of 93.64%. The company had revenue of $2.25 million during the quarter.
Milestone Scientific Company Profile
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Read More
- Five stocks we like better than Milestone Scientific
- Trading Halts Explained
- Top 5 High-Performance Cryptocurrency ETFs to Watch
- How to Invest in Blue Chip Stocks
- 3 Stocks That Plummeted After the Post-Fed Speech Crash
- The 3 Best Blue-Chip Stocks to Buy Now
- Adobe Stock: It’s Not Too Late To Buy The Dip
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
